scholarly journals Effect of Interval between Human Chorionic Gonadotropin Priming and Ovum Pick-up on the Euploid Probabilities of Blastocyst

2020 ◽  
Vol 9 (6) ◽  
pp. 1685
Author(s):  
Chun-I Lee ◽  
Hsiu-Hui Chen ◽  
Chun-Chia Huang ◽  
Chien-Hong Chen ◽  
En-Hui Cheng ◽  
...  

This retrospective study attempts to elucidate the relevance of the interval between human chorionic gonadotropin priming and oocyte pick-up (hCG-OPU) to the euploidy probability of biopsied blastocysts in preimplantation genetic tests for aneuploidy (PGT-A) cycles. A total of 1889 blastocysts from 511 patients undergoing PGT- A cycles were used. An analysis of generalized estimating equations (GEE) was used to identify whether the hCG–OPU interval is associated with euploidy probabilities of blastocysts. Accordingly, maternal age (OR: 0.925, 95% CI: 0.903–0.948, p < 0.001) and the hCG–OPU interval (OR: 1.138, 95% CI: 1.028–1.260, p = 0.013) were the two significant factors associated with the euploidy probabilities. The Cochran-Armitage trend test demonstrated that the blastocyst euploidy percentage increased progressively with the increasing hCG-OPU interval in normal responders (p = 0.006) and advanced maternal age (age ≥38 years; p = 0.020) groups. In normal responders, the euploidy rate was highest in the 38–39 h interval (43.1%, 47/109). In contrast, the euploidy rate was lowest in the 34–35 h interval (28.7%, 29/105). In conclusion, the present study demonstrated that at an hCG-OPU interval between 34–39 h, the longer the hCG-OPU interval, the higher the probability of euploidy for blastocysts.

2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Deborah T. Gold ◽  
David L. Weinstein ◽  
Gerhardt Pohl ◽  
Kelly D. Krohn ◽  
Yi Chen ◽  
...  

Purpose. Determine patient-reported reasons for discontinuation with teriparatide.Methods. Patients taking teriparatide in a multicenter, prospective, and observational study were given three questionnaires: baseline, follow-up questionnaire 1 (QF1, 2 to 6 months), and follow-up questionnaire 2 (QF2, 12 months). Discontinuation reported at QF1 and QF2 was defined as “early” and “late,” respectively, and remaining patients were considered persistent. Cochran-Armitage trend test was used to identify factors associated with discontinuation.Results. Side effects, concern about improper use, injection difficulties, and several patient-perceived physician issues were associated with early discontinuation. Low patient-perceived importance of continuing treatment, side effects, difficulty paying, and low patient-perceived physician knowledge were associated with late discontinuation. The most common specific reasons selected for discontinuing treatment were “concerns about treatment outweighing the benefits” (n=53) and “difficulty paying” (n=47).Conclusions. Persistence with teriparatide is dependent on managing side effects, addressing financial challenges, proper training, and obtaining support from the healthcare provider.


Placenta ◽  
2014 ◽  
Vol 35 (9) ◽  
pp. A51
Author(s):  
Camilla Haavaldsen ◽  
Peter Fedorcsak ◽  
Tom Tanbo ◽  
Anne Eskild

2014 ◽  
Vol 93 (12) ◽  
pp. 1290-1294 ◽  
Author(s):  
Camilla Haavaldsen ◽  
Peter Fedorcsak ◽  
Tom Tanbo ◽  
Anne Eskild

2015 ◽  
Vol 37 (6) ◽  
pp. 517-526 ◽  
Author(s):  
Ghayath Janoudi ◽  
Sherrie Kelly ◽  
Abdool Yasseen ◽  
Heba Hamam ◽  
Felipe Moretti ◽  
...  

2019 ◽  
Vol 112 (3) ◽  
pp. e130 ◽  
Author(s):  
Dimitar Parvanov ◽  
Dragomira Nikolova ◽  
Rumiana Ganeva ◽  
Kristina Nikolova ◽  
Magdalena Vasileva ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document